The 2024 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Praxis, or following a bona fide period of non-employment, as an ...
Researchers identified a key molecule that highlights how the immune system is linked to the release of dopamine.
Clinical Trials Arena on MSN
NRG doses first participants in Phase I trial for ALS and Parkinson’s
NRG Therapeutics has dosed the first participants in its Phase I clinical trial of NRG5051, being developed as a ...
ASPIRO is the first multi-patient, multi-center clinical trial of an autologous cell therapy for Parkinson's disease. It is evaluating safety, tolerability, and preliminary efficacy of ANPD001 in ...
Researchers say study findings may lead to a more promising future for cell therapy targeting stroke and other neurological disorders.
“Megan’s leadership has been a significant driver of Praxis’s success to date,” said Mr. Souza. “As COO, she is uniquely positioned to guide Praxis through its next phase, driving disciplined ...
A nanomaterial based on a platform developed by Professor Samuel Stupp crosses the blood-brain barrier and targets harmful ...
BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) ...
Neuronal arousal. You may be unfamiliar with the term, but you probably know the feeling. I experienced it the moment I ...
Sea anemones and jellyfish don’t have brains, but the way their neurons behave during sleep shows some surprising ...
Researchers have identified a previously unknown inflammatory mechanism that may drive the aggressiveness and relapse of ...
The prevalence of overweight and obesity is largely driven by the widespread availability of high-calorie and highly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback